HighVista Strategies »

Mbx Biosciences shares owned by HighVista Strategies

Quarter-by-quarter ownership of Mbx Biosciences (MBX) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Mbx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Mbx Biosciences held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mbx Biosciences by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2026-03-31 $342k 12k 29.85

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Praxis Precision Medicines I Com New (PRAX)
Cogent Biosciences (COGT)
Spyre Therapeutics Com New (SYRE)
Vaxcyte (PCVX)
Revolution Medicines (RVMD)
Terns Pharmaceuticals (TERN)
Structure Therapeutics Sponsored Ads (GPCR)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Soleno Therapeutics (SLNO)
Tyra Biosciences (TYRA)
Amylyx Pharmaceuticals (AMLX)
Amazon (AMZN)

View all positions for HighVista Strategies

Top funds holding Mbx Biosciences

Frazier Life Sciences Management
OrbiMed Advisors
NEA Management Company
Wellington Management Company
BlackRock
FMR
Deep Track Capital
NVP Associates
Vanguard Group
Polar Capital Holdings
Braidwell
Vanguard Capital Management
Aaron Wealth Advisors
Cormorant Asset Management
Driehaus Capital Management

View all funds holding Mbx Biosciences